(Q34145339)

31 July 2017

title

Wilms' tumor 1 as a novel target for immunotherapy of leukemia (English)

1 reference

31 July 2017

Wilms' Tumor 1 as a Novel Target for Immunotherapy of Leukemia (English)

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2010.07.034

8 August 2024

1 reference

1 reference

R. Casalegno-Garduño

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20970678

8 August 2024

A. Schmitt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20970678

8 August 2024

X. Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20970678

8 August 2024

X. Xu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20970678

8 August 2024

M. Schmitt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20970678

8 August 2024

language of work or name

English

0 references

publication date

1 October 2010

1 reference

full work available at URL

31 July 2017

https://api.elsevier.com/content/article/PII:S0041134510010791?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2010.07.034

https://api.elsevier.com/content/article/PII:S0041134510010791?httpAccept=text/plain

8 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2010.07.034

Transplantation Proceedings

8 August 2024

published in

1 reference

31 July 2017

volume

42

1 reference

31 July 2017

issue

8

1 reference

31 July 2017

page(s)

3309-3311

1 reference

Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cells

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.034

Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.034

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.034

Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.034

Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.034

Graft-versus-leukemia effects of transplantation and donor lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.034

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.034

Cellular immune responses to autologous chronic myelogenous leukaemia cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.034

In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.034

Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.034

Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.034

Discrepant expression of membrane and soluble isoforms of Fas (CD95/APO-1) in adult T-cell leukaemia: soluble Fas isoform is an independent risk factor for prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.034

Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.034

Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.034

Expression of the Wilms' tumor gene (WT1) in human leukemias

7 January 2021

2

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2010.07.034

The inhibition of lymphokine-activated killer cells in acute myeloblastic leukemia is mediated by transforming growth factor-beta 1

8 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2010.07.034

Different types of human leukemias express the message for TNF-alpha and interleukin-10

8 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2010.07.034

8 August 2024

Identifiers

1 reference

31 July 2017

1 reference